Alcon Inc.’s ALC growth is driven by its robust ... The renowned pharmaceutical and medical device manufacturer has a market capitalization of $48.21 billion. ALC’s earnings surpassed ...

Cooper’s pricing power and cost optimization efforts are expected to drive margin expansion. Read why I reiterate a Buy ...

The company, known for its medical devices and vision care offerings, continues to demonstrate resilience in a market characterized by both challenges and opportunities. Alcon's core business ...

Begin your TipRanks Premium journey today. Alcon (ALC) Company Description: Alcon Inc. is a medical company which is specialized in eye care products. The company develops, manufactures ...

In the medical field, uses include the treatment ... Polyquad was formulated in the mid 1980s by Alcon as a preservative for contact lens storage solutions. It was developed because other ...

The MCN Center for Victim Services received a $1,515,235 grant from Family Violence Prevention and Services/Domestic Violence ...

Medical device peers Alcon, Cooper Cos. and Johnson & Johnson own 25% to 40% of the market for contact lenses vs. 10% for Bausch + Lomb. In pharmaceuticals, AbbVie would encounter antitrust ...

A top medical device regulator’s work overlapped ... of a 12-person panel that considered approval of a lens implant by Alcon, an eye care drug and device maker and a client of Ms. Shuren ...

A real-world study of an FDA-approved gene therapy for inherited retinal disease shows younger patients gain more visual ...

The first step to finding a better price for contact lenses is to find an affordable vision exam to get your prescription.

Even in areas of tech that have done better, bosses note that the war is undermining morale and productivity. What is more, ...

Regarding distributions, we view Novartis’ dividends and share repurchases as about right. Novartis has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, ...